Page last updated: 2024-10-24

celiprolol and Aortic Aneurysm, Thoracic

celiprolol has been researched along with Aortic Aneurysm, Thoracic in 2 studies

Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.

Aortic Aneurysm, Thoracic: An abnormal balloon- or sac-like dilatation in the wall of the THORACIC AORTA. This proximal descending portion of aorta gives rise to the visceral and the parietal branches above the aortic hiatus at the diaphragm.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Gorosabel, MC2
Dubacher, N2
Meienberg, J2
Matyas, G2
Münger, J1
Crabb, J1
Ksiazek, AA1
Caspar, SM1
Bakker, ENTP1
van Bavel, E1
Ziegler, U1
Carrel, T1
Steinmann, B1
Zeisberger, S1

Other Studies

2 other studies available for celiprolol and Aortic Aneurysm, Thoracic

ArticleYear
Vascular Ehlers-Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?
    European heart journal. Cardiovascular pharmacotherapy, 2020, 07-01, Volume: 6, Issue:3

    Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic

2020
Celiprolol but not losartan improves the biomechanical integrity of the aorta in a mouse model of vascular Ehlers-Danlos syndrome.
    Cardiovascular research, 2020, 02-01, Volume: 116, Issue:2

    Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Tho

2020